Factors determining cellular mechanisms of resistance to antimitotic drugs
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 4 (1) , 3-8
- https://doi.org/10.1054/drup.2000.0172
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven PolymerizationJournal of Biological Chemistry, 1997
- Paclitaxel (Taxol®) Mechanisms of ResistancePublished by Springer Nature ,1996
- Characterization of a Taxol‐resistant Human Small‐cell Lung Cancer Cell LineJapanese Journal of Cancer Research, 1994
- Structure and Utilization of Tubulin IsotypesAnnual Review of Cell Biology, 1988
- A Mechanism of Cellular Resistance to Drugs that Interfere with Microtubule AssemblyaAnnals of the New York Academy of Sciences, 1986
- Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin.The Journal of cell biology, 1986
- Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly.The Journal of cell biology, 1983
- Isolation of Chinese hamster ovary cell mutants requiring the continuous presence of taxol for cell division.The Journal of cell biology, 1983
- The james ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancerCancer, 1983